性器疣贅の世界市場レポート 2025年

性器疣贅市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR5.4％で25億7,000万米ドルに成長します。予測期間の成長は、遠隔診察や治療モニタリングのための遠隔医療やデジタルヘルスプラットフォームの採用、STIに対する効果的で手ごろな価格の治療に対する需要の高まり、ループ電気外科的切除術の人気の高まり、インターフェロンアルファ-n3注射の需要の高まり、治療薬の入手可能性の増加などに起因すると考えられます。予測期間における主な動向としては、診断技術の進歩、併用療法へのシフト、遠隔医療やオンライン診察の拡大、新規治療ターゲットの出現、新興市場での拡大などが挙げられます。

性感染症（STI）の有病率の上昇が性器疣贅市場の成長を牽引すると予想されます。STIは、主に膣、肛門、オーラルセックスなどの性的接触によって感染し、細菌、ウイルス、寄生虫によって引き起こされます。STI有病率の増加は、性行為の増加、保護具の不十分な使用、教育やヘルスケアへのアクセスの制限に起因しています。一般的なSTIである性器疣贅は、ヒトパピローマウイルス（HPV）の特定の株によって引き起こされ、性行為中の皮膚と皮膚の直接接触によって広がります。例えば、スイスに本部を置く国連合同エイズ計画（Joint United Nations Programme on HIV/AIDS）は2023年10月、HIV感染者が2021年の3,870万人から2022年には3,900万人に増加し、2022年には130万人が新たに感染したと報告しました。このようなSTIの蔓延が性器疣贅市場の拡大に拍車をかけています。

性器疣贅市場の企業は、性器疣贅患者のニーズに対応するため、新しい皮膚科治療薬などの革新的な治療オプションの開発に注力しています。皮膚科治療薬は、性器疣贅を含む様々な皮膚疾患の治療を目的として新たに開発された医薬品です。例えば、2023年3月、米国の皮膚科企業であるVerrica Pharmaceuticals Inc.は、同社の医薬品候補であるYCANTHについて、FDAからNCE（New Chemical Entity）ステータスを取得しました。第2相臨床試験を終了したYCANTHは、性器疣贅の治療薬として開発されており、NCEステータスのため、少なくとも5年間はジェネリック医薬品との競合から保護されることになります。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界性器疣贅PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の性器疣贅市場：成長率分析
• 世界の性器疣贅市場の実績：規模と成長, 2019-2024
• 世界の性器疣贅市場の予測：規模と成長, 2024-2029, 2034F
• 世界性器疣贅総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の性器疣贅市場薬剤の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• イミキモド
• ポドフィリン
• ポドフィロックス
• トリクロロ酢酸
• 世界の性器疣贅市場治療別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 化学治療
• アブレーション治療
• 予防治療
• その他の治療法
• 世界の性器疣贅市場性別：、実績と予測, 2019-2024, 2024-2029F, 2034F
• 女性
• 男
• 世界の性器疣贅市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• クリニック
• 在宅ケア設定
• 世界の性器疣贅市場イミキモドの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• イミキモドクリーム5％
• イミキモドクリーム3.75%
• 世界の性器疣贅市場ポドフィリンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ポドフィリン樹脂10％
• ポドフィリン樹脂25％
• 世界の性器疣贅市場ポドフィロックスの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ポドフィロックスゲル0.5%
• ポドフィロックス溶液0.5%
• 世界の性器疣贅市場トリクロロ酢酸の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• トリクロロ酢酸80～90％
• トリクロロ酢酸50～70％

第7章 地域別・国別分析

• 世界の性器疣贅市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の性器疣贅市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 性器疣贅市場：競合情勢
• 性器疣贅市場：企業プロファイル
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 3M Company Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Teva Pharmaceutical Industries Ltd.
• Bausch Health Companies Inc.
• Sun Pharmaceuticals
• Perrigo Company plc
• Glenmark Pharmaceutical Inc.
• Taro Pharmaceutical Industries Ltd.
• Serum Institute of India Pvt. Ltd.
• ANI Pharmaceuticals Inc.
• Ligand Pharmaceuticals Incorporated
• Orgenesis Inc.
• Verrica Pharmaceuticals Inc.
• CryoConcepts LP
• CryoIQ Global AB
• Cassiopea Inc.
• Aresus Pharma Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 性器疣贅市場2029：新たな機会を提供する国
• 性器疣贅市場2029：新たな機会を提供するセグメント
• 性器疣贅市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Genital warts, also known as condylomata acuminata, are sexually transmitted infections caused by specific strains of the human papillomavirus (HPV). These warts typically manifest as small growths or clusters of bumps in or around the genital and anal areas. They can vary in size and shape, may be raised or flat, and often have a cauliflower-like appearance. Although generally painless, genital warts can lead to itching, discomfort, or bleeding during sexual intercourse.

The primary medications for treating genital warts include imiquimod, podophyllin, podofilox, and trichloroacetic acid. Imiquimod is a topical cream that works by stimulating the immune system to combat HPV-related warts. Treatment options also encompass chemical treatments, ablative treatments, preventive treatments, and other therapeutic approaches. These treatments are used by both females and males in various settings, such as hospitals, clinics, and home care environments.

The genital warts market research report is one of a series of new reports from The Business Research Company that provides genital warts market statistics, including genital warts industry global market size, regional shares, competitors with a genital warts market share, detailed genital warts market segments, market trends and opportunities, and any further data you may need to thrive in the genital warts industry. This genital warts market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The genital warts market size has grown strongly in recent years. It will grow from $1.97 billion in 2024 to $2.08 billion in 2025 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to the focus on patient-centered care, growing emphasis on early detection and treatment, increasing availability of therapies developed for self-target applications, and the increase in clinical trials and recurrence of genital warts.

The genital warts market size is expected to see strong growth in the next few years. It will grow to $2.57 billion in 2029 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to the adoption of telemedicine and digital health platforms for remote consultation and treatment monitoring, growing demand for effective and affordable treatments for STIs, the emerging popularity of loop electrosurgical excision procedures, the escalating demand for interferon alfa-n3 injection and increasing availability of therapies. Major trends in the forecast period include advancements in diagnostic technologies, a shift towards combination therapies, expansion of telehealth and online consultations, emergence of novel therapeutic targets, and expansion in emerging markets.

The rising prevalence of sexually transmitted infections (STIs) is expected to drive growth in the genital warts market. STIs, transmitted primarily through sexual contact such as vaginal, anal, and oral sex, are caused by bacteria, viruses, or parasites. The increase in STI prevalence is attributed to higher sexual activity, insufficient use of protection, and limited access to education and healthcare. Genital warts, a common STI, are caused by specific strains of human papillomavirus (HPV) and spread through direct skin-to-skin contact during sexual activity. For example, the Joint United Nations Programme on HIV/AIDS, based in Switzerland, reported in October 2023 that HIV infections rose from 38.7 million in 2021 to 39.0 million in 2022, with 1.3 million new infections in 2022. This growing prevalence of STIs is fueling the expansion of the genital warts market.

Companies in the genital warts market are focusing on developing innovative treatment options, such as new dermatology drugs, to address the needs of patients with genital warts. Dermatology drugs are newly developed pharmaceuticals aimed at treating various skin conditions, including genital warts. For instance, in March 2023, Verrica Pharmaceuticals Inc., a US-based dermatology company, received New Chemical Entity (NCE) status from the FDA for its drug candidate YCANTH. YCANTH, which has completed phase 2 trials, is being developed to treat genital warts and will benefit from at least five years of protection from generic competition due to its NCE status.

In April 2024, Endo, Inc., a US-based pharmaceutical company specializing in generics and specialty-branded products, acquired Endo International plc for an undisclosed amount. This acquisition aims to bolster Endo, Inc.'s portfolio in both generic and specialty pharmaceuticals, enhancing its ability to support patients and healthcare providers. Endo International plc is also a US-based company specializing in generics and specialty-branded pharmaceuticals.

Major companies operating in the genital warts market are Merck & Co.Inc., AbbVie Inc, Sanofi S.A, Novartis AG, 3M Company, Teva Pharmaceutical Industries Ltd, Bausch Health Companies Inc, Sun Pharmaceuticals, Perrigo Company plc, Glenmark Pharmaceutical Inc, Taro Pharmaceutical Industries Ltd, Serum Institute of India Pvt. Ltd., ANI Pharmaceuticals Inc, Ligand Pharmaceuticals Incorporated, Orgenesis Inc, Verrica Pharmaceuticals Inc, CryoConcepts LP, CryoIQ global AB, Cassiopea Inc, Aresus Pharma Inc.

North America was the largest region in the genital warts market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genital warts market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the genital warts market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The genital warts market consists of revenues earned by entities by providing services such as medical consultations, diagnostic testing, treatment procedures, follow-up care, and patient education programs. The market value includes the value of related goods sold by the service provider or included within the service offering. The genital warts market also includes sales of topical treatments, cryotherapy devices, surgical instruments, immune response modifiers, and antiviral medications. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Genital Warts Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on genital warts market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for genital warts ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The genital warts market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Type: Imiquimod; Podophyllin; Podofilox; Trichloroacetic Acid
• 2) By Treatment: Chemical Treatment; Ablative Treatment; Preventive Treatment; Other Treatments
• 3) By Gender: Female; Male
• 4) By End Users: Hospitals; Clinics; Home Care Settings

Subsegmments

• 1) By Imiquimod: Imiquimod Cream 5%; Imiquimod Cream 3.75%
• 2) By Podophyllin: Podophyllin Resin 10%; Podophyllin Resin 25%
• 3) By Podofilox: Podofilox Gel 0.5%; Podofilox Solution 0.5%
• 4) By Trichloroacetic Acid: Trichloroacetic Acid 80-90%; Trichloroacetic Acid 50-70%
• Companies Mentioned: Merck & Co.Inc.; AbbVie Inc; Sanofi S.A; Novartis AG; 3M Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Genital Warts Market Characteristics

3. Genital Warts Market Trends And Strategies

4. Genital Warts Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Genital Warts Growth Analysis And Strategic Analysis Framework

• 5.1. Global Genital Warts PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Genital Warts Market Growth Rate Analysis
• 5.4. Global Genital Warts Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Genital Warts Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Genital Warts Total Addressable Market (TAM)

6. Genital Warts Market Segmentation

• 6.1. Global Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Imiquimod
• Podophyllin
• Podofilox
• Trichloroacetic Acid
• 6.2. Global Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chemical Treatment
• Ablative Treatment
• Preventive Treatment
• Other Treatments
• 6.3. Global Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Female
• Male
• 6.4. Global Genital Warts Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Home Care Settings
• 6.5. Global Genital Warts Market, Sub-Segmentation Of Imiquimod, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Imiquimod Cream 5%
• Imiquimod Cream 3.75%
• 6.6. Global Genital Warts Market, Sub-Segmentation Of Podophyllin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Podophyllin Resin 10%
• Podophyllin Resin 25%
• 6.7. Global Genital Warts Market, Sub-Segmentation Of Podofilox, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Podofilox Gel 0.5%
• Podofilox Solution 0.5%
• 6.8. Global Genital Warts Market, Sub-Segmentation Of Trichloroacetic Acid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Trichloroacetic Acid 80-90%
• Trichloroacetic Acid 50-70%

7. Genital Warts Market Regional And Country Analysis

• 7.1. Global Genital Warts Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Genital Warts Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Genital Warts Market

• 8.1. Asia-Pacific Genital Warts Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Genital Warts Market

• 9.1. China Genital Warts Market Overview
• 9.2. China Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Genital Warts Market

• 10.1. India Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Genital Warts Market

• 11.1. Japan Genital Warts Market Overview
• 11.2. Japan Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Genital Warts Market

• 12.1. Australia Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Genital Warts Market

• 13.1. Indonesia Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Genital Warts Market

• 14.1. South Korea Genital Warts Market Overview
• 14.2. South Korea Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Genital Warts Market

• 15.1. Western Europe Genital Warts Market Overview
• 15.2. Western Europe Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Genital Warts Market

• 16.1. UK Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Genital Warts Market

• 17.1. Germany Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Genital Warts Market

• 18.1. France Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Genital Warts Market

• 19.1. Italy Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Genital Warts Market

• 20.1. Spain Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Genital Warts Market

• 21.1. Eastern Europe Genital Warts Market Overview
• 21.2. Eastern Europe Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Genital Warts Market

• 22.1. Russia Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Genital Warts Market

• 23.1. North America Genital Warts Market Overview
• 23.2. North America Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Genital Warts Market

• 24.1. USA Genital Warts Market Overview
• 24.2. USA Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Genital Warts Market

• 25.1. Canada Genital Warts Market Overview
• 25.2. Canada Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Genital Warts Market

• 26.1. South America Genital Warts Market Overview
• 26.2. South America Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Genital Warts Market

• 27.1. Brazil Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Genital Warts Market

• 28.1. Middle East Genital Warts Market Overview
• 28.2. Middle East Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Genital Warts Market

• 29.1. Africa Genital Warts Market Overview
• 29.2. Africa Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Genital Warts Market Competitive Landscape And Company Profiles

• 30.1. Genital Warts Market Competitive Landscape
• 30.2. Genital Warts Market Company Profiles
  • 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. 3M Company Overview, Products and Services, Strategy and Financial Analysis

31. Genital Warts Market Other Major And Innovative Companies

• 31.1. Teva Pharmaceutical Industries Ltd.
• 31.2. Bausch Health Companies Inc.
• 31.3. Sun Pharmaceuticals
• 31.4. Perrigo Company plc
• 31.5. Glenmark Pharmaceutical Inc.
• 31.6. Taro Pharmaceutical Industries Ltd.
• 31.7. Serum Institute of India Pvt. Ltd.
• 31.8. ANI Pharmaceuticals Inc.
• 31.9. Ligand Pharmaceuticals Incorporated
• 31.10. Orgenesis Inc.
• 31.11. Verrica Pharmaceuticals Inc.
• 31.12. CryoConcepts LP
• 31.13. CryoIQ Global AB
• 31.14. Cassiopea Inc.
• 31.15. Aresus Pharma Inc.

32. Global Genital Warts Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Genital Warts Market

34. Recent Developments In The Genital Warts Market

35. Genital Warts Market High Potential Countries, Segments and Strategies

• 35.1 Genital Warts Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Genital Warts Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Genital Warts Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer